Literature DB >> 21972258

Biologic mechanisms of oral cancer pain and implications for clinical therapy.

C T Viet1, B L Schmidt.   

Abstract

Cancer pain is an ever-present public health concern. With innovations in treatment, cancer patients are surviving longer, but uncontrollable pain creates a poor quality of life for these patients. Oral cancer is unique in that it causes intense pain at the primary site and significantly impairs speech, swallowing, and masticatory functions. We propose that oral cancer pain has underlying biologic mechanisms that are generated within the cancer microenvironment. A comprehensive understanding of key mediators that control cross-talk between the cancer and peripheral nervous system, and possible interventions, underlies effective cancer pain management. The purpose of this review is to explore the current studies on oral cancer pain and their implications in clinical management for cancer pain in general. Furthermore, we will explore the endogenous opioid systems and novel cancer pain therapeutics that target these systems, which could solve the issue of opiate tolerance and improve quality of life in oral cancer patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21972258      PMCID: PMC3327727          DOI: 10.1177/0022034511424156

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  66 in total

1.  Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion.

Authors:  J R Goss; M Mata; W F Goins; H H Wu; J C Glorioso; D J Fink
Journal:  Gene Ther       Date:  2001-04       Impact factor: 5.250

2.  Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission.

Authors:  Keiichi Niikura; Minoru Narita; Eduardo R Butelman; Mary Jeanne Kreek; Tsutomu Suzuki
Journal:  Trends Pharmacol Sci       Date:  2010-05-12       Impact factor: 14.819

3.  A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain.

Authors:  Bruno Georg Oertel; Mattias Kettner; Klaus Scholich; Christoph Renné; Bianca Roskam; Gerd Geisslinger; Peter Harald Schmidt; Jörn Lötsch
Journal:  J Biol Chem       Date:  2008-12-30       Impact factor: 5.157

4.  Herpes vector-mediated expression of proenkephalin reduces bone cancer pain.

Authors:  James R Goss; Cara F Harley; Marina Mata; Mark E O'Malley; William F Goins; XiaoPing Hu; Joseph C Glorioso; David J Fink
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

5.  Nerve growth factor and tyrosine kinase A receptor in oral squamous cell carcinoma: is there an association with perineural invasion?

Authors:  Antonia Kolokythas; Darren P Cox; Nusi Dekker; Brian L Schmidt
Journal:  J Oral Maxillofac Surg       Date:  2010-04-03       Impact factor: 1.895

Review 6.  Prevalence of pain in patients with cancer: a systematic review of the past 40 years.

Authors:  M H J van den Beuken-van Everdingen; J M de Rijke; A G Kessels; H C Schouten; M van Kleef; J Patijn
Journal:  Ann Oncol       Date:  2007-03-12       Impact factor: 32.976

7.  Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons.

Authors:  J Braz; C Beaufour; A Coutaux; A L Epstein; F Cesselin; M Hamon; M Pohl
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

8.  Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate.

Authors:  E J Simon; J M Hiller; I Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

Review 9.  A human trial of HSV-mediated gene transfer for the treatment of chronic pain.

Authors:  D Wolfe; M Mata; D J Fink
Journal:  Gene Ther       Date:  2009-02-26       Impact factor: 5.250

10.  Local injection of a selective endothelin-B receptor agonist inhibits endothelin-1-induced pain-like behavior and excitation of nociceptors in a naloxone-sensitive manner.

Authors:  Alla Khodorova; Moin U Fareed; Alexander Gokin; Gary R Strichartz; Gudarz Davar
Journal:  J Neurosci       Date:  2002-09-01       Impact factor: 6.167

View more
  34 in total

1.  Novel animal models of acute and chronic cancer pain: a pivotal role for PAR2.

Authors:  David K Lam; Dongmin Dang; Jianan Zhang; John C Dolan; Brian L Schmidt
Journal:  J Neurosci       Date:  2012-10-10       Impact factor: 6.167

2.  Effect of Mas-related gene (Mrg) receptors on hyperalgesia in rats with CFA-induced inflammation via direct and indirect mechanisms.

Authors:  Jianping Jiang; Dongmei Wang; Xiaolong Zhou; Yuping Huo; Tingjun Chen; Fenjuan Hu; Rémi Quirion; Yanguo Hong
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

3.  Neurotrophin Pathway Receptors NGFR and TrkA Control Perineural Invasion, Metastasis, and Pain in Oral Cancer.

Authors:  Coleen Doan; Bradley E Aouizerat; Yi Ye; Dongmin Dang; Kesava Asam; Aditi Bhattacharya; Timothy Howard; Yogin K Patel; Dan T Viet; Johnny D Figueroa; Jiang F Zhong; Carissa M Thomas; Anthony B Morlandt; Gary Yu; Nicholas F Callahan; Clint T Allen; Anupama Grandhi; Alan S Herford; Paul C Walker; Khanh Nguyen; Stephanie C Kidd; Steve C Lee; Jared C Inman; Jason M Slater; Chi T Viet
Journal:  Adv Biol (Weinh)       Date:  2022-08-04

4.  Advances in Head and Neck Cancer Pain.

Authors:  Y Ye; D D Jensen; C T Viet; H L Pan; W M Campana; M Amit; M D Boada
Journal:  J Dent Res       Date:  2022-04-13       Impact factor: 8.924

Review 5.  Essentials of oral cancer.

Authors:  César Rivera
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Mas-related G-protein-coupled receptor c agonist bovine adrenal medulla 8-22 attenuates bone cancer pain in mice.

Authors:  Yu-E Sun; Cui-E Lu; Yishan Lei; Yue Liu; Zhengliang Ma; Xiaoping Gu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 7.  Epigenetic regulation of persistent pain.

Authors:  Guang Bai; Ke Ren; Ronald Dubner
Journal:  Transl Res       Date:  2014-05-29       Impact factor: 7.012

8.  The Histopathology of Oral Cancer Pain in a Mouse Model and a Human Cohort.

Authors:  K Naik; M N Janal; J Chen; D Bandary; B Brar; S Zhang; J C Dolan; B L Schmidt; D G Albertson; A Bhattacharya
Journal:  J Dent Res       Date:  2020-10-08       Impact factor: 6.116

9.  Insufficient pain control for patients with cancer and dementia during terminal cancer stages.

Authors:  Wei-Hung Hsu; Jyh-Gang Hsieh; Ying-Wei Wang; Chia-Jung Hsieh; Huang-Ren Lin; Szu-Yuan Wu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 10.  Neuroimmunology of cancer and associated symptomology.

Authors:  Nicole N Scheff; Jami L Saloman
Journal:  Immunol Cell Biol       Date:  2021-09-12       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.